These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36765282)

  • 1. Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer.
    Yu Y; Sun Y; Li Z; Li J; Tian D
    BMC Bioinformatics; 2023 Feb; 24(1):44. PubMed ID: 36765282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiomics data identifies RSPO2 as a prognostic biomarker in human tumors associated with pan-cancer.
    Srivastava A; Srivastava S
    Adv Protein Chem Struct Biol; 2024; 139():469-499. PubMed ID: 38448143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer.
    Zhong H; Shi Q; Wen Q; Chen J; Li X; Ruan R; Zeng S; Dai X; Xiong J; Li L; Lei W; Deng J
    Front Immunol; 2023; 14():1058627. PubMed ID: 36923407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCND1 as a Prognostic and Diagnostic Biomarker and the Impact of Its Epigenetic Alterations on Cancer Survival.
    Taha MY; Mohamed NO; Alhaj LG; Altayeb I; Basheer A; Idrees S; Said AM; Alfaki M
    Cureus; 2024 Jul; 16(7):e65504. PubMed ID: 39188436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
    Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
    Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers.
    Yang L; Wei J; Ma X; Cheng R; Zhang H; Jin T
    Oncology; 2024; 102(2):168-182. PubMed ID: 37699361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics analysis of TLCD1 as a promising biomarker in pan-cancer.
    Wang S; Zhang M; Sun H; Li T; Hao J; Fang M; Dong J; Xu H
    Front Cell Dev Biol; 2023; 11():1305906. PubMed ID: 38559424
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer.
    Zhang L; Li X; Zhang J; Xu G
    Front Cell Dev Biol; 2021; 9():763674. PubMed ID: 35127701
    [No Abstract]   [Full Text] [Related]  

  • 12. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
    Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
    PeerJ; 2022; 10():e14432. PubMed ID: 36518297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.
    Tu Z; Peng J; Long X; Li J; Wu L; Huang K; Zhu X
    Front Immunol; 2022; 13():844736. PubMed ID: 35592314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
    Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
    Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer.
    Luo Z; He Z; Qin H; Chen Y; Qi B; Lin J; Sun Y; Sun J; Su X; Long Z; Chen S
    Front Pharmacol; 2022; 13():1053137. PubMed ID: 36467072
    [No Abstract]   [Full Text] [Related]  

  • 16. Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker.
    Xu L; Wu P; Rong A; Li K; Xiao X; Zhang Y; Wu H
    Aging (Albany NY); 2023 May; 15(10):4269-4287. PubMed ID: 37199628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response.
    Zheng H; Wang M; Zhang S; Hu D; Yang Q; Chen M; Zhang X; Zhang Y; Dai J; Liou YC
    Int J Biol Sci; 2023; 19(14):4689-4708. PubMed ID: 37781040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Cancer Analysis Revealed
    Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
    J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-cancer analysis of the prognostic and immunological role of RPL4.
    Liu Y; Li W; Zhou S; Cui M; Zhang L
    Heliyon; 2024 Jul; 10(14):e34461. PubMed ID: 39114029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
    Ju Q; Li XM; Zhang H; Zhao YJ
    Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.